Lyxumia, known generically as lixisenatide, is a medication used in the treatment of type 2 diabetes. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Lyxumia works by increasing the release of insulin when blood sugar levels are high, thereby reducing the amount of glucose in the blood. It also slows down the passage of food through the stomach, which can help control blood sugar levels and appetite. Lyxumia is typically administered via injection and is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.